Cospharm is a Southern African generic pharmaceutical company with physical presence in Namibia, Zimbabwe, Botswana and South Africa. The company sells, markets and distributes healthcare products throughout these countries and increasingly in emerging markets within Southern Africa.
The company started in 2010 with one retail outlet in Namibia. With aggressive focus on growth, these retails have since grown to 8 outlets in Namibia, Botswana and Zimbabwe. In 2014 the company ventured into generic pharmaceutical development. By 2018 more than 50 products have been registered in more than 4 countries and a vast pipeline of new products are under registration with various regulatory authorities in Southern Africa.
With its wide range of Acute antibiotic medicines, Cardiovascular (CVS) medicines, Female Hormone medicines and Impressive NSAID/ Analgesic range, Cospharm expects to be a key market player in the region.
The growth success of the company is attributed in part to highly qualified personnel with a clear pharmaceutical market understanding and in part to its practice of partnering with best manufacturers globally. In this respect Cospharm differs from other generic pharmaceutical companies, who rely on internal expertise and development.